Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Moxifloxacin (400mg) Tablet
Therapeutic Category
Antibacterials, Antibiotic, Respiratory
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x5
Price
₹144/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxifloxacin 400mg tablet is a fluoroquinolone antibiotic formulation used for the effective management of bacterial infections in the respiratory tract, skin, and soft tissues.
It works by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and ensuring potent antibacterial activity against susceptible pathogens.
This tablet is commonly prescribed for upper and lower respiratory tract infections, skin infections, sinusitis, and other systemic bacterial infections, providing broad-spectrum coverage.
With strong clinical efficacy, high prescription acceptance, and wide antibacterial spectrum, this formulation enhances an anti-infective product portfolio and supports consistent therapeutic demand.
Common side effects may include nausea, vomiting, diarrhea, dizziness, headache, or mild abdominal discomfort. Rarely, tendonitis, tendon rupture, or QT prolongation may occur; report any unusual symptoms to a physician promptly.
Moxolunic 400 Tablet is indicated for the treatment of respiratory tract infections, skin and soft tissue infections, intra-abdominal infections, and other bacterial infections caused by susceptible organisms, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Complete the full prescribed course to prevent antibiotic resistance. Not effective against viral infections. Inform your doctor of any heart, liver, or kidney conditions before use.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Cephalexin (500mg)
Composition : Doxycycline (100mg) + Lactobacillus (5Billion Spores)
Composition : Amoxycillin Trihydrate I.P. 250mg + Cloxacillin I.P. 250mg + Lactic Acid Bacillus 1.7 Billion Spores
Composition : Amoxycillin (500mg)
Composition : Amoxycillin (250mg)
Composition : Azithromycin (250mg) Tablet
Composition : Azithromycin (500mg) Tablet
Composition : Cefixime (200mg) + Lactobacillus (2.5Billion Spores)
Composition : Doxycycline (100mg) + Lactobacillus (5Million spores)
Composition : Azithromycin (100mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Moxifloxacin Tablets have strong demand in the broad-spectrum anti-infective segment, making them a high-value product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for respiratory tract infections, sinusitis, skin infections, and complicated bacterial infections, ensuring consistent prescription-driven demand.
Medical distributors and agencies benefit from the strong hospital and physician-driven antibiotic market. Broad-spectrum antibiotic effective against respiratory and soft tissue infections Commonly used for pneumonia, sinusitis, bronchitis, and skin infections Widely prescribed by physicians, pulmonologists, and surgeons Important in moderate to severe bacterial infection management High acceptance in hospital and clinical prescriptions Often used when first-line antibiotics are not sufficient This makes it a strong fast-moving prescription antibiotic product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 400 mg Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from consistent infection-related prescription demand, strong hospital and clinic usage, repeat sales in respiratory and soft tissue infections, and stable year-round turnover in the anti-infective segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete anti-infective product portfolio access to build a strong presence in the antibiotic market.